JF
AURA icon

Jump Financial’s Aura Biosciences AURA Stock Holding History

Jump Financial’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$518K Buy
+73,000
New +$522K ﹤0.01% 1439
2024
Q2 		– Sell
-12,398
Closed -$97.3K – 1799
2024
Q1 		$97.3K Buy
+12,398
New +$103K ﹤0.01% 1791

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Jump Financial's AURA Position: Q2 2026 in Review

Jump Financial opened a new position in Aura Biosciences (AURA) in Q2 2026: 73,000 shares worth $518K. The stake represents ﹤0.01% of the portfolio and ranks #1439 among its holdings. This is a return to the name: Jump Financial previously reported a position in AURA as recently as Q1 2024.

Jump Financial first reported a position in AURA in Q1 2024 and has held it in 2 quarters since. 146 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Jump Financial held 73,000 shares of Aura Biosciences worth $518K as of Q2 2026.
  • Aura Biosciences was a new Jump Financial position in Q2 2026.
  • Aura Biosciences made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1439 holding.
  • Jump Financial first reported a position in Aura Biosciences in Q1 2024 and has held it in 2 quarters since.
  • 146 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.